mardi 19 novembre 2019

Onco Actu du 19 novembre 2019


1.1 BIOLOGIE - GÉNOME



Genetic alterations caused by cancer therapies identified [IRB]










1.3 PRIX NOBEL



U.S. Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy [The Cancer Letter]










3.1.1 PRÉVENTION - TABAC - E-CIGS



President Trump: Don’t fail America’s children on flavored e-cigarettes [STAT]











Politics, Industry Backlash Stall White House Ban On Flavored Vaping Products [NPR]











California sues e-cigarette maker Juul for selling nicotine products to youth [Reuters]











4.15 DÉP., DIAG. & PRONO. - IMAGERIE



Radiation from CT scans associated with increased risk for cancer [EurekAlert!]










5.1 TRAITEMENTS - PRÉ-CLINIQUE



Combination treatment shows promise for pancreatic cancer [Garvan Institute]











One-two punch drug combination offers hope for pancreatic cancer therapy [Sanford Burnham Prebys]











New screening method identifies inhibitors of cancer cell metabolism [UCLA]











5.10 TRAITEMENTS - ESSAIS



Sharing clinical trial data: lessons from the YODA Project [STAT]











Long-term Survival Rate for Subset of Patients With Advanced Melanoma Following BRAF- and MEK-targeted Treatment Combination Higher Than Historical Rate [AACR]











5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



Potential new approach to T-cell therapy shows early promise in the lab [OICR]











5.2 PHARMA



Novartis reshapes China R&D hub to reflect rapidly evolving market [Biopharma Dive]











Novartis switches gears in Shanghai from research to drug development [Reuters]











5.4 TRAITEMENTS - ECONOMIE



Drug companies exaggerate — controlling drug prices won't threaten innovation [The Hill]











6.10 POLITIQUES



NHS staff shortages: urgent action needed to safeguard cancer services and help more people survive [Cancer Research UK]